United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes
In the late 1990s, the World Health Organization (WHO) created the Medical Eligibility Criteria for Contraceptive Use (MEC), which provide evidence‐based recommendations for safe and effective contraception in women with medical problems. The WHO MEC incorporate the best available evidence, are peri...
Gespeichert in:
| Veröffentlicht in: | Journal of midwifery & women's health 2011-11, Vol.56 (6), p.598-607 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 607 |
|---|---|
| container_issue | 6 |
| container_start_page | 598 |
| container_title | Journal of midwifery & women's health |
| container_volume | 56 |
| creator | Jacobson, Janet C. Aikins Murphy, Patricia |
| description | In the late 1990s, the World Health Organization (WHO) created the Medical Eligibility Criteria for Contraceptive Use (MEC), which provide evidence‐based recommendations for safe and effective contraception in women with medical problems. The WHO MEC incorporate the best available evidence, are periodically updated, and are designed to be modified for specific populations. The US Centers for Disease Control and Prevention published US MEC in 2010. Changes to WHO guidelines for use in the US population include the following areas: breastfeeding, intrauterine device use, valvular heart disease, ovarian cancer, uterine fibroids, and venous thromboembolism. Medical conditions not covered by WHO recommendations but added to the US MEC include contraceptive guidance for women with inflammatory bowel disease, history of bariatric surgery, rheumatoid arthritis, endometrial hyperplasia, history of peripartum cardiomyopathy, and history of solid organ transplant. This article reviews the changes and additions to WHO MEC found in the US MEC. |
| doi_str_mv | 10.1111/j.1542-2011.2011.00093.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_902809862</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1000270368</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4983-755de9a05d217274e74974ce28b3218e2cc4bf2b760a98c65447693cba814e563</originalsourceid><addsrcrecordid>eNqNkcFv0zAYxSMEYmPwLyCLC7ukfLYTO0ZcpmiswDokWFWJi-U4X4ZLmhQ73dr_HncZPXBA8-HZkn_vfbZekhAKExrXu-WE5hlLGVA6uRcAUHyyfZIcHy6e7s9MpCpn_Ch5EcISgEpQ8Dw5YgwERDlOfsw7N2BNvg9mwEBmWDtrWnLeuhtXudYNO1L6SHhnSNN7Uvbd4I3F9eBukcwDkjgL3pMz8g1vHd6RviHlT9PdYHiZPGtMG_DVw36SzD-eX5fT9PLrxafy7DK1mSp4KvO8RmUgrxmVTGYoMyUzi6yoOKMFMmuzqmGVFGBUYUWeZVIobitT0AxzwU-St2Pu2ve_NxgGvXLBYtuaDvtN0ApYAaoQLJKn_yUpMA6KCqkegQIwCVwUEX3zD7rsN76LX46jBZc5lzRCxQhZ34fgsdFr71bG72KS3neql3pfnd5XN8p9p3obra8f8jfVCuuD8W-JEfgwAneuxd2jg_Xn2WKqeLSno92FAbcHu_G_tJDx-XpxdaGnlH9ZzNS1vuJ_AJTQugg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>906375371</pqid></control><display><type>article</type><title>United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><creator>Jacobson, Janet C. ; Aikins Murphy, Patricia</creator><creatorcontrib>Jacobson, Janet C. ; Aikins Murphy, Patricia</creatorcontrib><description>In the late 1990s, the World Health Organization (WHO) created the Medical Eligibility Criteria for Contraceptive Use (MEC), which provide evidence‐based recommendations for safe and effective contraception in women with medical problems. The WHO MEC incorporate the best available evidence, are periodically updated, and are designed to be modified for specific populations. The US Centers for Disease Control and Prevention published US MEC in 2010. Changes to WHO guidelines for use in the US population include the following areas: breastfeeding, intrauterine device use, valvular heart disease, ovarian cancer, uterine fibroids, and venous thromboembolism. Medical conditions not covered by WHO recommendations but added to the US MEC include contraceptive guidance for women with inflammatory bowel disease, history of bariatric surgery, rheumatoid arthritis, endometrial hyperplasia, history of peripartum cardiomyopathy, and history of solid organ transplant. This article reviews the changes and additions to WHO MEC found in the US MEC.</description><identifier>ISSN: 1526-9523</identifier><identifier>EISSN: 1542-2011</identifier><identifier>DOI: 10.1111/j.1542-2011.2011.00093.x</identifier><identifier>PMID: 22060220</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>Birth control ; breastfeeding ; Changes ; contraception ; Contraception - methods ; Contraceptive Agents, Female - adverse effects ; Contraceptive Agents, Female - therapeutic use ; Contraceptives ; Contraindications ; Criteria ; Drug Interactions ; Eligibility ; Eligibility Determination ; Evidence-based medicine ; Evidence-Based Practice ; Female ; Heart diseases ; Humans ; MEC ; Medical disorders ; Nursing ; postpartum ; Practice Guidelines as Topic ; Rheumatoid arthritis ; United States ; United States Medical Eligibility Criteria for Contraceptive Use ; Women ; Women's Health ; World Health Organization</subject><ispartof>Journal of midwifery & women's health, 2011-11, Vol.56 (6), p.598-607</ispartof><rights>2011 by the American College of Nurse‐Midwives</rights><rights>2011 by the American College of Nurse-Midwives.</rights><rights>Copyright Elsevier Science Ltd. Nov/Dec 2011</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4983-755de9a05d217274e74974ce28b3218e2cc4bf2b760a98c65447693cba814e563</citedby><cites>FETCH-LOGICAL-c4983-755de9a05d217274e74974ce28b3218e2cc4bf2b760a98c65447693cba814e563</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1542-2011.2011.00093.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1542-2011.2011.00093.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>315,782,786,1419,27931,27932,31006,31007,45581,45582</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22060220$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Jacobson, Janet C.</creatorcontrib><creatorcontrib>Aikins Murphy, Patricia</creatorcontrib><title>United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes</title><title>Journal of midwifery & women's health</title><addtitle>J Midwifery Womens Health</addtitle><description>In the late 1990s, the World Health Organization (WHO) created the Medical Eligibility Criteria for Contraceptive Use (MEC), which provide evidence‐based recommendations for safe and effective contraception in women with medical problems. The WHO MEC incorporate the best available evidence, are periodically updated, and are designed to be modified for specific populations. The US Centers for Disease Control and Prevention published US MEC in 2010. Changes to WHO guidelines for use in the US population include the following areas: breastfeeding, intrauterine device use, valvular heart disease, ovarian cancer, uterine fibroids, and venous thromboembolism. Medical conditions not covered by WHO recommendations but added to the US MEC include contraceptive guidance for women with inflammatory bowel disease, history of bariatric surgery, rheumatoid arthritis, endometrial hyperplasia, history of peripartum cardiomyopathy, and history of solid organ transplant. This article reviews the changes and additions to WHO MEC found in the US MEC.</description><subject>Birth control</subject><subject>breastfeeding</subject><subject>Changes</subject><subject>contraception</subject><subject>Contraception - methods</subject><subject>Contraceptive Agents, Female - adverse effects</subject><subject>Contraceptive Agents, Female - therapeutic use</subject><subject>Contraceptives</subject><subject>Contraindications</subject><subject>Criteria</subject><subject>Drug Interactions</subject><subject>Eligibility</subject><subject>Eligibility Determination</subject><subject>Evidence-based medicine</subject><subject>Evidence-Based Practice</subject><subject>Female</subject><subject>Heart diseases</subject><subject>Humans</subject><subject>MEC</subject><subject>Medical disorders</subject><subject>Nursing</subject><subject>postpartum</subject><subject>Practice Guidelines as Topic</subject><subject>Rheumatoid arthritis</subject><subject>United States</subject><subject>United States Medical Eligibility Criteria for Contraceptive Use</subject><subject>Women</subject><subject>Women's Health</subject><subject>World Health Organization</subject><issn>1526-9523</issn><issn>1542-2011</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>7QJ</sourceid><recordid>eNqNkcFv0zAYxSMEYmPwLyCLC7ukfLYTO0ZcpmiswDokWFWJi-U4X4ZLmhQ73dr_HncZPXBA8-HZkn_vfbZekhAKExrXu-WE5hlLGVA6uRcAUHyyfZIcHy6e7s9MpCpn_Ch5EcISgEpQ8Dw5YgwERDlOfsw7N2BNvg9mwEBmWDtrWnLeuhtXudYNO1L6SHhnSNN7Uvbd4I3F9eBukcwDkjgL3pMz8g1vHd6RviHlT9PdYHiZPGtMG_DVw36SzD-eX5fT9PLrxafy7DK1mSp4KvO8RmUgrxmVTGYoMyUzi6yoOKMFMmuzqmGVFGBUYUWeZVIobitT0AxzwU-St2Pu2ve_NxgGvXLBYtuaDvtN0ApYAaoQLJKn_yUpMA6KCqkegQIwCVwUEX3zD7rsN76LX46jBZc5lzRCxQhZ34fgsdFr71bG72KS3neql3pfnd5XN8p9p3obra8f8jfVCuuD8W-JEfgwAneuxd2jg_Xn2WKqeLSno92FAbcHu_G_tJDx-XpxdaGnlH9ZzNS1vuJ_AJTQugg</recordid><startdate>201111</startdate><enddate>201111</enddate><creator>Jacobson, Janet C.</creator><creator>Aikins Murphy, Patricia</creator><general>Blackwell Publishing Inc</general><general>Wiley Subscription Services, Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QJ</scope><scope>ASE</scope><scope>FPQ</scope><scope>K6X</scope><scope>NAPCQ</scope><scope>7X8</scope></search><sort><creationdate>201111</creationdate><title>United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes</title><author>Jacobson, Janet C. ; Aikins Murphy, Patricia</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4983-755de9a05d217274e74974ce28b3218e2cc4bf2b760a98c65447693cba814e563</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Birth control</topic><topic>breastfeeding</topic><topic>Changes</topic><topic>contraception</topic><topic>Contraception - methods</topic><topic>Contraceptive Agents, Female - adverse effects</topic><topic>Contraceptive Agents, Female - therapeutic use</topic><topic>Contraceptives</topic><topic>Contraindications</topic><topic>Criteria</topic><topic>Drug Interactions</topic><topic>Eligibility</topic><topic>Eligibility Determination</topic><topic>Evidence-based medicine</topic><topic>Evidence-Based Practice</topic><topic>Female</topic><topic>Heart diseases</topic><topic>Humans</topic><topic>MEC</topic><topic>Medical disorders</topic><topic>Nursing</topic><topic>postpartum</topic><topic>Practice Guidelines as Topic</topic><topic>Rheumatoid arthritis</topic><topic>United States</topic><topic>United States Medical Eligibility Criteria for Contraceptive Use</topic><topic>Women</topic><topic>Women's Health</topic><topic>World Health Organization</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jacobson, Janet C.</creatorcontrib><creatorcontrib>Aikins Murphy, Patricia</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>British Nursing Index</collection><collection>British Nursing Index (BNI) (1985 to Present)</collection><collection>British Nursing Index</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of midwifery & women's health</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jacobson, Janet C.</au><au>Aikins Murphy, Patricia</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes</atitle><jtitle>Journal of midwifery & women's health</jtitle><addtitle>J Midwifery Womens Health</addtitle><date>2011-11</date><risdate>2011</risdate><volume>56</volume><issue>6</issue><spage>598</spage><epage>607</epage><pages>598-607</pages><issn>1526-9523</issn><eissn>1542-2011</eissn><abstract>In the late 1990s, the World Health Organization (WHO) created the Medical Eligibility Criteria for Contraceptive Use (MEC), which provide evidence‐based recommendations for safe and effective contraception in women with medical problems. The WHO MEC incorporate the best available evidence, are periodically updated, and are designed to be modified for specific populations. The US Centers for Disease Control and Prevention published US MEC in 2010. Changes to WHO guidelines for use in the US population include the following areas: breastfeeding, intrauterine device use, valvular heart disease, ovarian cancer, uterine fibroids, and venous thromboembolism. Medical conditions not covered by WHO recommendations but added to the US MEC include contraceptive guidance for women with inflammatory bowel disease, history of bariatric surgery, rheumatoid arthritis, endometrial hyperplasia, history of peripartum cardiomyopathy, and history of solid organ transplant. This article reviews the changes and additions to WHO MEC found in the US MEC.</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>22060220</pmid><doi>10.1111/j.1542-2011.2011.00093.x</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1526-9523 |
| ispartof | Journal of midwifery & women's health, 2011-11, Vol.56 (6), p.598-607 |
| issn | 1526-9523 1542-2011 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_902809862 |
| source | MEDLINE; Access via Wiley Online Library; Applied Social Sciences Index & Abstracts (ASSIA) |
| subjects | Birth control breastfeeding Changes contraception Contraception - methods Contraceptive Agents, Female - adverse effects Contraceptive Agents, Female - therapeutic use Contraceptives Contraindications Criteria Drug Interactions Eligibility Eligibility Determination Evidence-based medicine Evidence-Based Practice Female Heart diseases Humans MEC Medical disorders Nursing postpartum Practice Guidelines as Topic Rheumatoid arthritis United States United States Medical Eligibility Criteria for Contraceptive Use Women Women's Health World Health Organization |
| title | United States Medical Eligibility Criteria for Contraceptive Use 2010: A Review of Changes |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-05T03%3A08%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=United%20States%20Medical%20Eligibility%20Criteria%20for%20Contraceptive%20Use%202010:%20A%20Review%20of%20Changes&rft.jtitle=Journal%20of%20midwifery%20&%20women's%20health&rft.au=Jacobson,%20Janet%20C.&rft.date=2011-11&rft.volume=56&rft.issue=6&rft.spage=598&rft.epage=607&rft.pages=598-607&rft.issn=1526-9523&rft.eissn=1542-2011&rft_id=info:doi/10.1111/j.1542-2011.2011.00093.x&rft_dat=%3Cproquest_cross%3E1000270368%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=906375371&rft_id=info:pmid/22060220&rfr_iscdi=true |